Terms: = Bone cancer AND ZRSR2, URP, 8233, ENSG00000169249, U2AF1RS2, MGC142040, U2AF1L2, U2AF1-RS2, MGC142014 AND Treatment
2 results:
1. Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS).
Berman E; Jhanwar S; Hedvat C; Arcila ME; Wahab OA; Levine R; Maloy M; Ma W; Albitar M
Leuk Res; 2016 Oct; 49():108-12. PubMed ID: 27658269
[TBL] [Abstract] [Full Text] [Related]
2. Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.
Konopacki J; Porcher R; Robin M; Bieri S; Cayuela JM; Larghero J; Xhaard A; Andreoli AL; Dhedin N; Petropoulou A; Rodriguez-Otero P; Ribaud P; Moins-Teisserenc H; Carmagnat M; Toubert A; Chalandon Y; Socie G; Peffault de Latour R
Haematologica; 2012 May; 97(5):710-6. PubMed ID: 22180425
[TBL] [Abstract] [Full Text] [Related]
